Tectonic Therapeutic (TECX) has had the highest return since January 1, 2024 by a US stock, returning 5,611,150%.
| ASSET | % RETURN |
|---|---|
Tectonic Therapeutic (TECX) | 5,611,150% |
Nexalin Technology (NXLIW) | 7,647.89% |
Iteris (ITI) | 5,315.5% |
Wearable Devices (WLDSW) | 3,900% |
Triller (ILLRW) | 3,178.69% |
TSS, Inc Common Stock (TSSI) | 2,607.41% |
GeneDx (WGS) | 2,569.26% |
Bright Minds Biosciences (DRUG) | 2,073.15% |
Sezzle Inc Common Stock (SEZL) | 2,024.05% |
LENZ Therapeutics (LENZ) | 1,859.69% |
GeneDx (WGSWW) | 1,635% |
BM Technologies Inc WT (BMTX.WT) | 1,524.55% |
Fitell Corporation Ordinary Shares (FTEL) | 1,469.08% |
Zivo Bioscience (ZIVO) | 1,455.56% |
NeoVolta Inc Warrant (NEOVW) | 1,311.41% |
CompoSecure (CMPOW) | 1,160.53% |
Mobiquity Technologies (MOBQ) | 1,100.58% |
Monopar Therapeutics (MNPR) | 1,090.94% |
Codere Online Luxembourg SA Warrants (CDROW) | 1,010.33% |
Palladyne AI (PDYNW) | 999% |
Root (ROOT) | 949.9% |
Dave (DAVE) | 911.29% |
Nexalin Technology (NXL) | 830.79% |
Roth CH Acquisition V Co Warrant (ROCLW) | 814.54% |
Core Scientific, Inc Tranche 2 Warrants (CORZZ) | 775% |
